Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

NCT00676832 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative

Interventions

DRUG: Placebo
DRUG: COLAL-PRED

Sponsor

Prometheus Laboratories